会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • NEW SELF EMULSIFYING DRUG DELIVERY SYSTEM
    • 新型自动感染药物输送系统
    • WO2003022249A1
    • 2003-03-20
    • PCT/SE2002/001598
    • 2002-09-05
    • ASTRAZENECA ABHOLMBERG, Christina
    • HOLMBERG, Christina
    • A61K9/107
    • A61K31/407A61K9/1075A61K9/4858A61K31/21A61K31/381A61K31/403A61K31/4035A61K31/405A61K31/685Y10S514/937Y10S514/938A61K2300/00
    • The present invention claims and discloses a pharmaceutical composition suitable for oral administration, in form of an emulsion pre-concentrate, comprising(i) one or more NO-releasing NSAID(s);(ii) one or more surfactants, of which at least one is phospholipid;said composition forming an in-situ oil-in-water emulsion upon contact with gastrointestinal fluids. The composition may optionally also comprise an additional oil or semi-solid fat. Further, one or more short-chain alcohols can optionally be included in the composition. Also within the scope of the invention is a combination with a proton pump inhibitor. The pharmaceutical composition is useful in the treatment of pain and inflammation. Further within the scope of the invention is kit comprising a pharmaceutical composition according to the invention in a unit dosage form, in combination with a proton pump inhibitor, and said proton pump inhibitor is enteric coated.
    • 本发明要求并且公开了一种适于口服给药的药物组合物,其形式为乳液预浓缩物,其包含(i)一种或多种NO释放的NSAID;(ii)一种或多种表面活性剂,其至少 一种是磷脂;所述组合物在与胃肠液接触时形成原位水包油乳剂。 组合物可以任选地还包含另外的油或半固体脂肪。 此外,一种或多种短链醇可以任选地包括在组合物中。 也在本发明的范围内是与质子泵抑制剂的组合。 该药物组合物可用于治疗疼痛和炎症。 进一步在本发明的范围内的是包含根据本发明的药物组合物的单位剂型与质子泵抑制剂组合的试剂盒,所述质子泵抑制剂是肠溶包衣的。